改良型中等长度导管在肝胆胰患者中的应用研究  

The application effect of modified medium-length catheter in the intravenous therapy of hepato-bilio-pancreatic patients

作　　者：伊秋香 伊秀英[1] 周若霞[1] 尹玲[1] 郭丽华 YIN Qiu-xiang;YIN Xiu-ying;ZHOU Ruo-xia;YIN Lin;GUO Li-hua(The First Affiliated Hospital of Gannan Medical University,Ganzhou,Jiangxi 341000)

机构地区：[1]赣南医学院第一附属医院,江西赣州341000

出　　处：《赣南医学院学报》2021年第4期396-398,共3页JOURNAL OF GANNAN MEDICAL UNIVERSITY

摘　　要：目的:探讨改良型中等长度导管在肝胆胰患者静脉治疗中的应用效果,为合理选择血管通路装置、减少输液治疗并发症提供依据。方法:将2018年10月至2020年6月住院的90例患有肝胆胰疾病、静脉治疗时间>7 d、血管条件不佳的患者作为置管选择对象,随机分为3组,各30例:一组置改良型中等长度导管,二组置PICC导管,三组置留置针;观察3组置管患者静脉炎、手臂疼痛、堵管及导管相关性感染和血栓、静脉治疗费用消耗等情况。结果:改良型中等长度导管组静脉炎、手臂疼痛、堵管发生率低于留置针组,差异有统计学意义(P<0.001);而导管相关性血流感染和血栓发生率差异无统计学意义(P>0.05);与PICC组比较,并发症发生率差异无统计学意义(P>0.05)。三组患者静脉治疗费用消耗差异有统计学意义(P<0.001)。结论:肝胆胰疾病患者使用改良型中等长度导管进行静脉治疗,可减少并发症,减轻患者的痛苦,有PICC导管的大部分功能,静脉治疗消耗费用明显降低,故优于PICC和留置针。Objective:To investigate the application effect of modified medium-length catheter in the intravenous therapy of hepato-bilio-pancreatic patients,and to provide basis for the rational selection of vascular access devices and the re⁃duction of complications in infusion therapy.Methods:A total of 90 individuals hospitalized in our department from Oc⁃tober 2018 to June 2020,who were with hepatobiliary and pancreatic diseases,intravenous treatment for more than 7 days,and with poor vascular conditions were selected as subjects for catheterization.The patients were randomly divided into three groups:30 cases with modified medium-length catheter,30 cases with PICC catheter,and 30 cases with in⁃dwelling needle,respectively.Subsequently,the short-term outcomes concerning phlebitis,arm pain,catheter-related infections,thrombosis and cost of intravenous treatment were observed.Results:The incidence of phlebitis,arm pain,and catheter blockage in the modified medium-length catheter group was significantly lower than that in the indwelling needle group,with a significant statistical difference(P<0.001),while that of catheter-related bloodstream infection and thrombosis was not statistically significant(P>0.05).In addition,there was no remarkable difference in the inci⁃dence of complications between the modified medium-length catheter group and the PICC group(P>0.05).Further⁃more,the cost of intravenous therapy was significantly different among the three groups(P<0.001).Conclusion:Pa⁃tients with hepatobiliary and pancreatic diseases using modified medium length catheter for intravenous therapy can re⁃duce the complications and relieve the pain of patients.Therefore,it is superior to PICC catheter and indwelling needle in terms of that it has most of the functions of PICC catheter,and significantly reduces the cost of intravenous therapy.

关 键 词：改良型中等长度导管 肝胆胰患者 

分 类 号：R473[医药卫生—护理学]